NASDAQ : IMGN

ImmunoGen, Inc.

$31.235 USD

$0.01 (0.02%)

Volume
19.31M
Average Volume
9.19M
Market Capitalization
$8.73B
P/E Ratio
-35.54
Dividend Yield
0.00%
Price Target
$16.00
Year High
$31.25
Year Low
$3.61
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$2.26
IMGN vs. The Competition
Properties IMGN ALPN BPMC CERE
Market Cap $8.73B $4.46B $8.36B $8.19B
Shares Outstanding $279.35M $68.6M $64.58M $182.2M
P/E Ratio -35.54 -101.52 -120.99 -16.84
EPS -0.88 -0.64 -1.07 -2.67
Day Low 31.22 64.97 129.46 44.96
Day High 31.25 65 129.46 44.99
Year Low 3.61 8.33 73.04 19.59
Year High 31.25 65 129.55 44.99
Average Price 50 29.0404 52.4882 116.5207 41.5991
Average Price 200 18.86545 26.273676 98.82235 38.6717
Volume 19.31M 4.29M 2.98M 15.03M
Average Volume - - - -
IMGN Top Competitors
Symbol Name Last Change %Chg Volume
ALPN Alpine Immune Sciences, Inc. $64.97 0.01 0.02% 4.29M
BPMC Blueprint Medicines Corporation $129.46 0.18 0.14% 2.98M
CERE Cerevel Therapeutics Holdings, Inc. $44.96 0.33 0.74% 15.03M